GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Sergio Amadori, Valeria Calafiore et al.|Blood|2019Cited by 215
Methodology and clinical utility of longitudinal <scp><i>UBA1</i></scp> tracking in <scp>VEXAS</scp> syndromeCarmelo Gurnari, Maria Teresa Voso, Elisa Galossi et al.|British Journal of Haematology|2024Cited by 10